Loading clinical trials...

TERMINATEDPhase 2NCT05063734

A Study to Evaluate THR-687 Treatment for Diabetic Macular Oedema.

This study is conducted to select the THR-687 dose level (Part A of the study) and to assess the efficacy and safety of the selected dose level compared to aflibercept (Part B of the study).

Lead sponsor: Oxurion•18 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITINGPhase 1

A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)

NCT07425522 · Diabetic Macular Edema

RECRUITINGPhase 2

INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes

NCT07224321 · Type 1 Diabetes Mellitus

RECRUITINGPhase 2

A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus

NCT07340320 · Type II Diabetes Mellitus

RECRUITINGNA

Measurement of Ocular Blood Flow and Retinal Oxygen Extraction in Diabetic Patients

NCT07536516 · Diabetes Mellitus

RECRUITINGPhase 3

A Study of Baricitinib (LY3009104) for the Delay of Stage 3 Type 1 Diabetes in At-Risk Children and Adults

NCT07222137 · Diabetes Mellitus, Type 1

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 18, 2023Terms

Trial snapshot

StatusTERMINATED

PhasePHASE2

Enrollment16

Start dateAug 2021

Last updatedAug 18, 2023

Condition

Diabetes Mellitus Diabetic Retinopathy Diabetic Macular Edema

Locations shown

Salehi Retina Institute Inc.

Huntington Beach, California

California Eye Specialists Medical Group, Inc.

Pasadena, California

Retinal Consultants Medical Group

Sacramento, California

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 18, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions